Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tang Capital Partners
Biotech
Kezar rejects Concentra buyout that 'undervalues' the biotech
Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences.
James Waldron
Oct 17, 2024 9:10am
With Kezar in lupus limbo, Concentra spies potential acquisition
Oct 9, 2024 7:10am
Concentra scores another win as Theseus agrees to buyout offer
Dec 22, 2023 7:57am
Concentra back with another buyout offer, this time for LianBio
Dec 1, 2023 11:03am
Concentra offers to buy troubled Rain Oncology
Oct 16, 2023 10:20am
